Offer - Urjas Oil for just ₹ 1
Uniphos 500 Injection is a prescription medicine that is available as a Injection. Ovarian Cancer, Multiple Myeloma are some of its major therapeutic uses. The alternative uses of Uniphos 500 Injection have also been explained below.
The right dosage of Uniphos 500 Injection depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Uniphos 500 Injection can also lead to other problems, which have been listed below. These side effects of Uniphos 500 Injection are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Uniphos 500 Injection's effect is Severe during pregnancy and Severe for lactating mothers. Further, the section on Uniphos 500 Injection related warnings talks about Uniphos 500 Injection's effects on the liver, heart and kidney.
Some other conditions that can be affected by Uniphos 500 Injection are listed in the contraindications section below.
Additionally, Uniphos 500 Injection may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Uniphos 500 Injection is not safe while driving, and is is not addictive in nature.
Uniphos 500 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Geriatric |
|
Adult |
|
Is the use of Uniphos 500 Injection safe for pregnant women?
Uniphos should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Uniphos 500 Injection safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Uniphos. It should only be taken after medical advice.
What is the effect of Uniphos 500 Injection on the Kidneys?
Uniphos has very mild side effects on the kidneys.
What is the effect of Uniphos 500 Injection on the Liver?
Uniphos may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Uniphos 500 Injection on the Heart?
Very few cases of side effects of Uniphos on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Uniphos 500 Injection unless your doctor advises you to do so -
Is this Uniphos 500 Injection habit forming or addictive?
No, you will not get addicted to Uniphos 500 Injection.
Is it safe to drive or operate heavy machinery when consuming?
After taking Uniphos 500 Injection, you should not drive or work on any heavy machine, as Uniphos 500 Injection can make you drowsy.
Is it safe?
Yes, but take Uniphos 500 Injection only as per medical advice.
Is it able to treat mental disorders?
No, Uniphos 500 Injection cannot treat any kind of mental disorder.
Interaction between Food and Uniphos 500 Injection
Taking Uniphos 500 Injection with food does not harm your health.
Interaction between Alcohol and Uniphos 500 Injection
Information about the interaction of Uniphos 500 Injection and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cyclophosphamide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 860
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 375-377